Multivariate analysis of disease-free survival and overall survival in stage ii and iii crc patients and igfbp3 promoter methylation status.

Univariate and multivariate analyses of disease-free survival in stage II/III CRC.

Chunxiang Li (270599)
Sanjun Cai (122578)
Xishan Wang (282956)
Zheng Jiang (282949)

November 2014

*Statistically significant, P<0.05; CI, confidence interval.Univariate and multivar...

Detection rate of methylated CDO1 in the plasma of patients with CRC using a high volume of plasma-derived DNA template.

Keishi Yamashita (131002)
Mina Waraya (668981)
Myoung Sook Kim (91321)
David Sidransky (11085)
Natsuya Katada (668982)
Takeo Sato (164222)
Takatoshi Nakamura (668983)
Masahiko Watanabe (47746)

December 2014

(a) Q-MSP analysis of methylated CDO1 using a high amount of plasma-derived DNA of ...

Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors

Levine, A. Joan
Phipps, Amanda I.
Baron, John A.
Buchanan, Daniel D.
Ahnen, Dennis J.
Cohen, Stacey A.
Lindor, Noralane M.
Newcomb, Polly A.
Rosty, Christophe
Haile, Robert W.
Laird, Peter W.
Weisenberger, Daniel J.

January 2016

The CpG Island Methylator Phenotype (CIMP) is a major molecular pathway in colorectal cancer (CRC). ...

Multivariate analysis of disease-free survival based on IGFBP3 promoter methylation in stage II and III CRC patients.

Lucia Perez-Carbonell (481096)
Francesc Balaguer (105988)
Yuji Toiyama (130074)
Cecilia Egoavil (186851)
Estefania Rojas (5660245)
Carla Guarinos (186858)
Montserrat Andreu (133579)
Xavier Llor (133582)
Antoni Castells (105992)
Rodrigo Jover (133583)
C. Richard Boland (130077)
Ajay Goel (130080)

August 2014

CI: Confidence interval; mmr: mismatch repair; msi: microsatellite instability; mss: microsatelli...

Relationship between igfbp3 methylation and prognostic and predictive response in stage ii and iii crc patients.

Lucia Perez-Carbonell (481096)
Francesc Balaguer (105988)
Yuji Toiyama (130074)
Cecilia Egoavil (186851)
Estefania Rojas (5660245)
Carla Guarinos (186858)
Montserrat Andreu (133579)
Xavier Llor (133582)
Antoni Castells (105992)
Rodrigo Jover (133583)
C. Richard Boland (130077)
Ajay Goel (130080)

August 2014

(a) Disease-free survival of patients with stage ii and iii crc, according to igfbp3 methy...

Molecular features associated with gene methylation in crc patients.

Lucia Perez-Carbonell (481096)
Francesc Balaguer (105988)
Yuji Toiyama (130074)
Cecilia Egoavil (186851)
Estefania Rojas (5660245)
Carla Guarinos (186858)
Montserrat Andreu (133579)
Xavier Llor (133582)
Antoni Castells (105992)
Rodrigo Jover (133583)
C. Richard Boland (130077)
Ajay Goel (130080)

August 2014

*Evaluated with student's -t testSD: Standard deviation; l; mmr: mismatch repair; msi: mic...

CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer

Cleven, Arjen H. G.
Derks, Sarah
Draht, Muriel X. G.
Smits, Kim M.
Melotte, Veerle
Van Neste, Leander
Tournier, Benjamin
Jooste, Valerie
Chapusot, Caroline
Weijenberg, Matty P.
Herman, James G.
de Bruine, Adriaan P.
van Engeland, Manon

June 2014

Purpose: Data on the prognostic significance of promoter CpG island methylation in colorectal cancer...

CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer

Cleven, Arjen H.G.
Derks, Sarah
Draht, Muriel X.G.
Smits, Kim M.
Melotte, Veerle
Van Neste, Leander
Tournier, Benjamin
Jooste, Valerie
Chapusot, Caroline
Weijenberg, Matty P.
Herman, James G.
De Bruïne, Adriaan P.
Van Engeland, Manon

June 2014

Purpose: Data on the prognostic significance of promoter CpG island methylation in colorectal cancer...

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.

Katsuhiko Nosho
Natsumi Irahara
Kaori Shima
Shoko Kure
Gregory J Kirkner
Eva S Schernhammer
Aditi Hazra
David J Hunter
John Quackenbush
Donna Spiegelman
Edward L Giovannucci
Charles S Fuchs
Shuji Ogino

The CpG island methylator phenotype (CIMP) is a distinct phenotype associated with microsatellite in...

Kaplan–Meier survival curves depicting the effect of LINE-1 methylation on 3-year overall survival in early-onset CRC patients.

Marina Antelo (133544)
Francesc Balaguer (105988)
Jinru Shia (133551)
Yan Shen (12156)
Keun Hur (130070)
Leticia Moreira (133557)
Miriam Cuatrecasas (130067)
Luis Bujanda (22355)
Maria Dolores Giraldez (133561)
Masanobu Takahashi (130062)
Ana Cabanne (133565)
Mario Edmundo Barugel (133568)
Mildred Arnold (133573)
Enrique Luis Roca (133576)
Montserrat Andreu (133579)
Sergi Castellvi-Bel (133581)
Xavier Llor (133582)
Rodrigo Jover (133583)
Antoni Castells (105992)
C. Richard Boland (130077)
Ajay Goel (130080)

September 2012

Vertical tick marks indicate censored events. The green line represents survival in CRCs w...

A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival

Jia, Min
Zhang, Yan
Jansen, Lina
Walter, Viola
Edelmann, Dominic
Gündert, Melanie
Tagscherer, Katrin E.
Roth, Wilfried
Bewerunge-Hudler, Melanie
Herpel, Esther
Kloor, Matthias
Ulrich, Alexis
Burwinkel, Barbara
Bläker, Hendrik
Chang-Claude, Jenny
Brenner, Hermann
Hoffmeister, Michael

January 2019

Background: Results of previous studies on the association of the CpG island methylator phenotype (C...

S Ogino et al. CIMP, BRAF and Survival in Colon Cancer. Page 1 1

Shuji Ogino
Katsuhiko Nosho
Gregory J. Kirkner
Takako Kawasaki
Jeffrey A. Meyerhardt
Massimo Loda
Edward L. Giovannucci
Charles S. Fuchs

October 2016

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in c...

Research Article Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer

Yuwei Wang
Yadong Long
Ye Xu
Zuqing Guan
Peng Lian
Junjie Peng

January 2013

which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis

Juo, Y. Y.
Johnston, F. M.
Zhang, D. Y.
Juo, H. H.
Wang, H.
Pappou, E. P.
Yu, T.
Easwaran, H.
Baylin, S.
van Engeland, M.
Ahuja, N.

December 2014

Background: Divergent findings regarding the prognostic value of CpG island methylator phenotype (CI...

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases

Stacey A. Cohen
Ming Yu
Kelsey Baker
Mary Redman
Chen Wu
Tai J. Heinzerling
Ralph M. Wirtz
Elpida Charalambous
George Pentheroudakis
Vassiliki Kotoula
Konstantine T. Kalogeras
George Fountzilas
William M. Grady

May 2017

Abstract Background The CpG island methylator phenotype (CIMP) in stage III colon cancer (CRC) has b...

Univariate and multivariate analyses of disease-free survival in stage II/III CRC.

Chunxiang Li (270599)
Sanjun Cai (122578)
Xishan Wang (282956)
Zheng Jiang (282949)

November 2014

*Statistically significant, P<0.05; CI, confidence interval.Univariate and multivar...

Detection rate of methylated CDO1 in the plasma of patients with CRC using a high volume of plasma-derived DNA template.

Keishi Yamashita (131002)
Mina Waraya (668981)
Myoung Sook Kim (91321)
David Sidransky (11085)
Natsuya Katada (668982)
Takeo Sato (164222)
Takatoshi Nakamura (668983)
Masahiko Watanabe (47746)

December 2014

(a) Q-MSP analysis of methylated CDO1 using a high amount of plasma-derived DNA of ...

Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors

Levine, A. Joan
Phipps, Amanda I.
Baron, John A.
Buchanan, Daniel D.
Ahnen, Dennis J.
Cohen, Stacey A.
Lindor, Noralane M.
Newcomb, Polly A.
Rosty, Christophe
Haile, Robert W.
Laird, Peter W.
Weisenberger, Daniel J.

January 2016

The CpG Island Methylator Phenotype (CIMP) is a major molecular pathway in colorectal cancer (CRC). ...

Multivariate analysis of disease-free survival based on IGFBP3 promoter methylation in stage II and III CRC patients.

Lucia Perez-Carbonell (481096)
Francesc Balaguer (105988)
Yuji Toiyama (130074)
Cecilia Egoavil (186851)
Estefania Rojas (5660245)
Carla Guarinos (186858)
Montserrat Andreu (133579)
Xavier Llor (133582)
Antoni Castells (105992)
Rodrigo Jover (133583)
C. Richard Boland (130077)
Ajay Goel (130080)

August 2014

CI: Confidence interval; mmr: mismatch repair; msi: microsatellite instability; mss: microsatelli...

Relationship between igfbp3 methylation and prognostic and predictive response in stage ii and iii crc patients.

Lucia Perez-Carbonell (481096)
Francesc Balaguer (105988)
Yuji Toiyama (130074)
Cecilia Egoavil (186851)
Estefania Rojas (5660245)
Carla Guarinos (186858)
Montserrat Andreu (133579)
Xavier Llor (133582)
Antoni Castells (105992)
Rodrigo Jover (133583)
C. Richard Boland (130077)
Ajay Goel (130080)

August 2014

(a) Disease-free survival of patients with stage ii and iii crc, according to igfbp3 methy...

Molecular features associated with gene methylation in crc patients.

Lucia Perez-Carbonell (481096)
Francesc Balaguer (105988)
Yuji Toiyama (130074)
Cecilia Egoavil (186851)
Estefania Rojas (5660245)
Carla Guarinos (186858)
Montserrat Andreu (133579)
Xavier Llor (133582)
Antoni Castells (105992)
Rodrigo Jover (133583)
C. Richard Boland (130077)
Ajay Goel (130080)

August 2014

*Evaluated with student's -t testSD: Standard deviation; l; mmr: mismatch repair; msi: mic...

CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer

Cleven, Arjen H. G.
Derks, Sarah
Draht, Muriel X. G.
Smits, Kim M.
Melotte, Veerle
Van Neste, Leander
Tournier, Benjamin
Jooste, Valerie
Chapusot, Caroline
Weijenberg, Matty P.
Herman, James G.
de Bruine, Adriaan P.
van Engeland, Manon

June 2014

Purpose: Data on the prognostic significance of promoter CpG island methylation in colorectal cancer...

CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer

Cleven, Arjen H.G.
Derks, Sarah
Draht, Muriel X.G.
Smits, Kim M.
Melotte, Veerle
Van Neste, Leander
Tournier, Benjamin
Jooste, Valerie
Chapusot, Caroline
Weijenberg, Matty P.
Herman, James G.
De Bruïne, Adriaan P.
Van Engeland, Manon

June 2014

Purpose: Data on the prognostic significance of promoter CpG island methylation in colorectal cancer...

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.

Katsuhiko Nosho
Natsumi Irahara
Kaori Shima
Shoko Kure
Gregory J Kirkner
Eva S Schernhammer
Aditi Hazra
David J Hunter
John Quackenbush
Donna Spiegelman
Edward L Giovannucci
Charles S Fuchs
Shuji Ogino

The CpG island methylator phenotype (CIMP) is a distinct phenotype associated with microsatellite in...

Kaplan–Meier survival curves depicting the effect of LINE-1 methylation on 3-year overall survival in early-onset CRC patients.

Marina Antelo (133544)
Francesc Balaguer (105988)
Jinru Shia (133551)
Yan Shen (12156)
Keun Hur (130070)
Leticia Moreira (133557)
Miriam Cuatrecasas (130067)
Luis Bujanda (22355)
Maria Dolores Giraldez (133561)
Masanobu Takahashi (130062)
Ana Cabanne (133565)
Mario Edmundo Barugel (133568)
Mildred Arnold (133573)
Enrique Luis Roca (133576)
Montserrat Andreu (133579)
Sergi Castellvi-Bel (133581)
Xavier Llor (133582)
Rodrigo Jover (133583)
Antoni Castells (105992)
C. Richard Boland (130077)
Ajay Goel (130080)

September 2012

Vertical tick marks indicate censored events. The green line represents survival in CRCs w...

A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival

Jia, Min
Zhang, Yan
Jansen, Lina
Walter, Viola
Edelmann, Dominic
Gündert, Melanie
Tagscherer, Katrin E.
Roth, Wilfried
Bewerunge-Hudler, Melanie
Herpel, Esther
Kloor, Matthias
Ulrich, Alexis
Burwinkel, Barbara
Bläker, Hendrik
Chang-Claude, Jenny
Brenner, Hermann
Hoffmeister, Michael

January 2019

Background: Results of previous studies on the association of the CpG island methylator phenotype (C...

S Ogino et al. CIMP, BRAF and Survival in Colon Cancer. Page 1 1

Shuji Ogino
Katsuhiko Nosho
Gregory J. Kirkner
Takako Kawasaki
Jeffrey A. Meyerhardt
Massimo Loda
Edward L. Giovannucci
Charles S. Fuchs

October 2016

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in c...

Research Article Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer

Yuwei Wang
Yadong Long
Ye Xu
Zuqing Guan
Peng Lian
Junjie Peng

January 2013

which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis

Juo, Y. Y.
Johnston, F. M.
Zhang, D. Y.
Juo, H. H.
Wang, H.
Pappou, E. P.
Yu, T.
Easwaran, H.
Baylin, S.
van Engeland, M.
Ahuja, N.

December 2014

Background: Divergent findings regarding the prognostic value of CpG island methylator phenotype (CI...

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases

Stacey A. Cohen
Ming Yu
Kelsey Baker
Mary Redman
Chen Wu
Tai J. Heinzerling
Ralph M. Wirtz
Elpida Charalambous
George Pentheroudakis
Vassiliki Kotoula
Konstantine T. Kalogeras
George Fountzilas
William M. Grady

May 2017

Abstract Background The CpG island methylator phenotype (CIMP) in stage III colon cancer (CRC) has b...

Univariate and multivariate analyses of disease-free survival in stage II/III CRC.

Chunxiang Li (270599)
Sanjun Cai (122578)
Xishan Wang (282956)
Zheng Jiang (282949)

November 2014

*Statistically significant, P<0.05; CI, confidence interval.Univariate and multivar...

Detection rate of methylated CDO1 in the plasma of patients with CRC using a high volume of plasma-derived DNA template.

Keishi Yamashita (131002)
Mina Waraya (668981)
Myoung Sook Kim (91321)
David Sidransky (11085)
Natsuya Katada (668982)
Takeo Sato (164222)
Takatoshi Nakamura (668983)
Masahiko Watanabe (47746)

December 2014

(a) Q-MSP analysis of methylated CDO1 using a high amount of plasma-derived DNA of ...

Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors

Levine, A. Joan
Phipps, Amanda I.
Baron, John A.
Buchanan, Daniel D.
Ahnen, Dennis J.
Cohen, Stacey A.
Lindor, Noralane M.
Newcomb, Polly A.
Rosty, Christophe
Haile, Robert W.
Laird, Peter W.
Weisenberger, Daniel J.

January 2016

The CpG Island Methylator Phenotype (CIMP) is a major molecular pathway in colorectal cancer (CRC). ...

Multivariate analysis of disease-free survival and overall survival in stage ii and iii crc patients and <i>igfbp3</i> promoter methylation status.

Abstract

Extracted data

Multivariate analysis of disease-free survival and overall survival in stage ii and iii crc patients and <i>igfbp3</i> promoter methylation status.

Abstract

Extracted data

Related items

Related items